Andrew M. Kopelman

Medicine · Health Sciences

5h-index1.4kcitations7works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(2), CAR-T cell therapy research(2), Medical Malpractice and Liability Issues(2), Torture, Ethics, and Law(2), Cancer Cells and Metastasis(1)

Publications7 total

Duty to Protect
2019
Duty to Protect
Oxford University Press eBooks·2014
CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation
Cancer Cell·2010· 18 citedOpen Access
CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation
Cancer Cell·2010· 339 citedOpen Access
Requests for 692 Transfers to an Academic Level I Trauma Center: Implications of the Emergency Medical Treatment and Active Labor Act
The Journal of Trauma: Injury, Infection, and Critical Care·2007· 61 cited
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
Proceedings of the National Academy of Sciences·2006· 146 citedOpen Access
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Nature·2004· 869 cited

Frequent Co-authors

Dean W. Felsher(4), Qiwei Yang(3), Pavan Bachireddy(3), Alice C. Fan(3), Sandra Ryeom(3), Kavya Rakhra(2), Tahera Zabuawala(2), Robert Zeiser(2), Lior Z. Braunstein(2), Erika J. Crosby(2), Catherine M. Shachaf(1), Constadina Arvanitis(1), Åsa Karlsson(1), Shelly Beer(1), Stefanie Mandl(1), Michael H. Bachmann(1), Alexander D. Borowsky(1), Boris H. Ruebner(1), Robert D. Cardiff(1), J. Michael Bishop(1)